ArticleAntiviral research2022

Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain.

Guan-Chun Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.